Is epalrestat an effective treatment for diabetic peripheral neuropathy?

被引：3
作者：
Tesfaye, Solomon
机构：
[1] Royal Hallamshire Hosp, Diabet Neuropathy Study Grp, European Assoc Study Diabet, Sheffield S10 2JF, S Yorkshire, England
[2] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2007年 / 3卷 / 02期
关键词：
diabetes; epalrestat; glycemic control; neuropathy;
D O I：
10.1038/ncpendmet0395
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84 / 85
页数：2
相关论文
共 5 条
[1]   Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy - The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial [J].
Hotta, Nigishi ;
Akanuma, Yasuo ;
Kawamori, Ryuzo ;
Matsuoka, Kempe ;
Oka, Yoshitomo ;
Shichiri, Motoaki ;
Toyota, Takayoshi ;
Nakashima, Mitsuyosii ;
Yoshimura, Isao ;
Sakamoto, Nobuo ;
Shigeta, Yukio .
DIABETES CARE, 2006, 29 (07) :1538-1544
[2]   Opportunities afforded by the study of unmyelinated nerves in skin and other organs [J].
Kennedy, WR .
MUSCLE & NERVE, 2004, 29 (06) :756-767
[3]   Sural nerve pathology in diabetic patients with minimal but progressive neuropathy [J].
Malik, RA ;
Tesfaye, S ;
Newrick, PG ;
Walker, D ;
Rajbhandari, SM ;
Siddique, I ;
Sharma, AK ;
Boulton, AJM ;
King, RHM ;
Thomas, PK ;
Ward, JD .
DIABETOLOGIA, 2005, 48 (03) :578-585
[4]   IMPAIRED BLOOD-FLOW AND ARTERIOVENOUS SHUNTING IN HUMAN DIABETIC NEUROPATHY - A NOVEL TECHNIQUE OF NERVE PHOTOGRAPHY AND FLUORESCEIN ANGIOGRAPHY [J].
TESFAYE, S ;
HARRIS, N ;
JAKUBOWSKI, JJ ;
MODY, C ;
WILSON, RM ;
RENNIE, IG ;
WARD, JD .
DIABETOLOGIA, 1993, 36 (12) :1266-1274
[5]   Vascular risk factors and diabetic neuropathy [J].
Tesfaye, S ;
Chaturvedi, N ;
Eaton, SEM ;
Ward, JD ;
Manes, C ;
Ionescu-Tirgoviste, C ;
Witte, DR ;
Fuller, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :341-350
1